Detalhe da pesquisa
1.
Substratification of patients with newly diagnosed standard-risk multiple myeloma.
Br J Haematol
; 185(2): 254-260, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768679
2.
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.
Br J Haematol
; 187(5): 588-594, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298751
3.
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.
Blood
; 129(3): 299-306, 2017 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856462
4.
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.
Blood
; 129(15): 2111-2119, 2017 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126928
5.
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment.
Blood
; 129(1): 82-87, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729322
6.
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
Am J Hematol
; 94(3): 306-311, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516847
7.
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Am J Hematol
; 94(7): 751-756, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945330
8.
Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(10): 2127-2132, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656139
9.
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
Am J Hematol
; 93(7): 889-894, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659048
10.
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma.
Am J Hematol
; 93(2): 179-186, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067723
11.
OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.
Retina
; 38(7): 1371-1376, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29068915
12.
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
Br J Haematol
; 178(6): 888-895, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699650
13.
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
Am J Hematol
; 92(6): 549-554, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314084
14.
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
Am J Hematol
; 92(5): 435-440, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181278
15.
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
Am J Hematol
; 92(7): 668-673, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370486
16.
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.
Am J Hematol
; 92(9): E507-E512, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28568244
17.
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.
Blood
; 124(6): 907-12, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957143
18.
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type.
Haematologica
; 101(9): 1102-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27479823
19.
The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.
Nephrol Dial Transplant
; 31(8): 1284-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627634
20.
Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma.
Am J Hematol
; 91(6): 571-4, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945843